(Q42212668)

English

Early use of allogeneic hematopoietic stem cell transplantation for infants with MLL gene-rearrangement-positive acute lymphoblastic leukemia

scientific article published on 3 June 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Early use of allogeneic hematopoietic stem cell transplantation for infants with MLL gene-rearrangement-positive acute lymphoblastic leukemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

1 reference

based on heuristic

inferred from title

Daisuke Tomizawa

2

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

author name string

K Koh

1

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

A Moriya Saito

3

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

T Watanabe

4

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

T Miyamura

5

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

M Hirayama

6

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Y Takahashi

7

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

A Ogawa

8

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

K Kato

9

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

K Sugita

10

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

T Sato

11

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

T Deguchi

12

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Y Hayashi

13

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

J Takita

14

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Y Takeshita

15

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

M Tsurusawa

16

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

K Horibe

17

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

S Mizutani

18

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

E Ishii

19

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

publication date

3 June 2014

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

290-296

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.172

21 January 2018

A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.172

21 January 2018

Outcome of risk-based therapy for infant acute lymphoblastic leukemia with or without an MLL gene rearrangement, with emphasis on late effects: a final report of two consecutive studies, MLL96 and MLL98, of the Japan Infant Leukemia Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.172

21 January 2018

Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.172

21 January 2018

Intensified therapy for infants with acute lymphoblastic leukemia: results from the Dana-Farber Cancer Institute Consortium

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.172

21 January 2018

Treatment of infants with lymphoblastic leukaemia: results of the UK Infant Protocols 1987-1999.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.172

21 January 2018

Infant acute lymphoblastic leukemia with MLL gene rearrangements: outcome following intensive chemotherapy and hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.172

21 January 2018

Population pharmacokinetics of oral busulfan in young Japanese children before hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.172

21 January 2018

Modifications to induction therapy decrease risk of early death in infants with acute lymphoblastic leukemia treated on Children's Oncology Group P9407

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.172

21 January 2018

Outcome of recurrent or refractory acute lymphoblastic leukemia in infants with MLL gene rearrangements: A report from the Japan Infant Leukemia Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.172

21 January 2018

Analysis of the role of hematopoietic stem-cell transplantation in infants with acute lymphoblastic leukemia in first remission and MLL gene rearrangements: a report from the Children's Oncology Group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.172

21 January 2018

Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic options

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.172

21 January 2018

MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.172

21 January 2018

Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.172

21 January 2018

Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia (MLL)-rearranged acute lymphoblastic leukemia: results from the Interfant-99 Study.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.172

21 January 2018

Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24888273

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk-directed treatment of infant acute lymphoblastic leukaemia based on early assessment of MLL gene status: results of the Japan Infant Leukaemia Study (MLL96)

1 reference

https://pubmed.ncbi.nlm.nih.gov/24888273

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment outcome in infant acute lymphoblastic leukemia. Children Leukemia Cooperative Group--EORTC. European Organization for Research and Treatment of Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24888273

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biology and treatment of infant leukemias

1 reference

https://pubmed.ncbi.nlm.nih.gov/24888273

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic disposition and clinical outcomes in infants and children receiving intravenous busulfan for allogeneic hematopoietic stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24888273

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia--implications for treatment of infants

1 reference

https://pubmed.ncbi.nlm.nih.gov/24888273

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of treatment intensification in infants with acute lymphoblastic leukemia: results of two consecutive AIEOP studies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24888273

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region

1 reference

https://pubmed.ncbi.nlm.nih.gov/24888273

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/LEU.2014.172

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42212668&oldid=2205126887"